SINOVAC BIOTECH LTD. ANNOUNCES FIRST SALES OF ITS SEASONAL INFLUENZA VACCINE, ANFLU

Sinovac Biotech Ltd. announced that the third product of the Company, seasonal influenza vaccine, is successfully released for sale by National Institute for the Control of Pharmaceutical and Biological Products ("NICPBP"). On the same day, the first bunch of purchase orders is signed with several customers. These purchase orders represent a major step for the Company as its third vaccine product begins sales in China. And it is expected to be another major source to generate sales revenue for the Company. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=6148600)